Tag Archives: Hematology

ITALY – Gitmo: Italy one of the top ranked counties in Europe for bone marrow stem cell transplants

Italy is ranked among the top countries in Europe for the number of bone marrow transplants performed. This is one of the elements that emerged on the first day of the 3rd GITMO conference (Italian group for bone marrow transplants), which began today in Florence.

Italy plays a leading role for bone marrow transplants, said a statement, demonstrated by the fact that our country is one of the top contributors to the number of transplants performed in Europe. The European Bone Marrow Transplant Group (EMBT) collects and stores data regarding transplants performed in various countries, and Italy is
Read More…

Pennsylvania hospital in Gamida-Teva stem cell study

Image via Wikipedia

Western Pennsylvania Cancer Institute’s Dr. Entezam Sahovic: We are hopeful that this new technology will enable us to help more patients in need of transplants.

A joint venture between Gamida Cell and Teva Pharmaceutical Industries Ltd. will carry out a study at Western Pennsylvania Hospital (WPH). WPH is currently enrolling patients for the study.
The ExCell study will assess the safety and efficacy of StemEx as a treatment for hematological malignancies, including leukemia and lymphoma, in a single arm, global, pivotal registration study.
StemEx is a graft of expanded stem/progenitor cells, derived from a single unit of umbilical cord blood
Read More…

Adult Stem Cells May Target and Repair Heart Attack Damage

A 41-site clinical trial, testing the restorative effect that adult bone marrow stem cells have on damaged or injured myocardium in heart attack patients, is being led at Wake Forest Baptist by Sanjay Gandhi, MD.

Phase I of the research study found that stem cells derived from bone marrow (mesenchymal stem cells) were safe for patients and may have the ability to limit scar formation, improve heart function and preserve tissue following a first heart attack.

Phase I was a multicenter study of 53 patients which demonstrated that the treatment was safe in adults, and those patients given this
Read More…

Hutchinson cancer center gets 16.7mln USD for stem cells research

Two scientists at the Fred Hutchinson Cancer Research Center in Seattle have been awarded $16.7 million for stem cell research projects.
Dr. Irwin Bernstein and Beverly Torok-Storb received the federal funding from the National Heart, Lung and Blood Institute. Their award is part of a $170 million effort divided among 18 scientific teams.

Torok-Storb will work with Dr. Mortimer Poncz of Children’s Hospital of Philadelphia to develop molecular and cell-based therapies for a range of blood diseases, using an $8.2 million grant.
Bernstein will work with Edward Morrisey of the University of Pennsylvania to study how biochemical reactions inside cells affect cell
Read More…

New hope for SCID disease

Children born with so-called “bubble boy” disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years of outcome data by researchers at the Harvard-affiliated Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

Researchers say the findings support expanding newborn screening for severe combined immune deficiency (SCID), a disorder that leaves affected infants so vulnerable to infection that most die within the first year of life if untreated.

The study, published today in the New England Journal of Medicine, analyzed data on 240 children
Read More…